Credit Suisse is recommends taking advantage of recent weakness to buy Health Management (HMA...

|About: Health Management Associate... (HMA)|By:, SA News Editor

Credit Suisse is recommends taking advantage of recent weakness to buy Health Management (HMA +0.7%). The firm says it's not concerned with recent headlines and believes organic growth estimates will prove conservative. The firm rates the shares at Outperform with a $12 price target.